Tilray | TRLY - Umsatzkosten





Umsatzkosten Veränderung Datum
Akebia Therapeutics USD 10.34M 441K 2025-12
Alaunos Therapeutics USD 0 18K 2024-09
Aurora Cannabis CAD 8.22M 80.38M 2026-03
Avita Medical AUD 3.3M 166K 2025-12
Canopy Growth CAD 62.98M 9.91M 2026-03
Cronos Group USD 24.94M 1.55M 2026-06
Divis Laboratories Ltd INR 11.19B 1.2B 2026-06
Ionis Pharmaceuticals USD 2.74M 261K 2026-06
IQVIA Holdings USD 3.22B 141M 2026-06
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Moderna USD 93M 862M 2026-06
Organigram Holdings CAD 43.39M 13.54M 2026-03
Organon & Co USD 711M 34M 2026-06
Revvity USD 312.82M 10.64M 2026-06
Tilray USD 164.37M 8.41M 2025-09
Viatris USD 2.3B 59.5M 2026-06
Xeris Pharmaceuticals USD 10.57M 3.08M 2026-03
Zealand Pharma A/S 410K 5K 2025-06